GISGilead Sciences, Inc.
124.34EUR-1.55%Mkt Cap: 168.53B $P/E:

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, D…

Key Statistics

Company
Market Cap168.53B $
Enterprise Value189.74B $
Revenue (TTM)33.11B $
Gross Profit25.23B $
Net Income (TTM)9.25B $
Revenue/Share26.64 USD
Last Price124.34 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees17.0K
CountryDE
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS3755581036
Valuation
P/E (Trailing)
P/E (Forward)
PEG2.15
EV/EBITDA11.96
EV/Revenue5.73
P/S5.03
P/B7.54
EPS (TTM)-2.29
EPS (Forward)
52W Range
119.8460% of range127.34
52W High127.34 EUR
52W Low119.84 EUR
Profitability
Gross Margin78.83%
Oper. Margin33.68%
EBITDA Margin47.94%
Profit Margin28.90%
ROE37.49%
ROA14.42%
Growth
Revenue Growth10.20%
Earnings Growth
Cash Flow & Leverage
Operating CF10.89B $
CapEx (TTM)611.96M $
FCF Margin32.07%
FCF Yield6.30%
Net Debt23.22B $
Net Debt/EBITDA1.46
Balance Sheet
Debt/Equity1.10
Current Ratio1.26
Quick Ratio0.90
Book Value/Sh16.40 EUR
Cash/Share3.937 EUR
Dividends
Fwd Div Rate2.850 EUR
Trail. Div Rate3.220 EUR
Div. Yield2.38%
5Y Avg Yield3.55%
Payout Ratio43.40%
Ex-Div DateSep 15, 2026
Pay Date
Splits
Last Split2:1
Split DateJan 28, 2013
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.1.24B
Float1.24B
Insiders0.11%
Institutions92.57%
Technical
SMA 50113.42 (+9.6%)
SMA 200114.39 (+8.7%)
Beta0.34
S&P 52W Chg20.80%
Avg Vol (30d)1.39K
Avg Vol (10d)1.06K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)